Log In
Print
BCIQ
Print
Print this Print this
 

NeuroStat

  Manage Alerts
Collapse Summary General Information
Company NeuroVive Pharmaceutical AB
DescriptionCyclosporine A lipid emulsion formulated without Cremophor EL, a stabilizing solution
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase II
Standard IndicationShock / trauma
Indication DetailsTreat moderate and severe traumatic brain injury (TBI); Treat severe traumatic brain injury (TBI); Treat traumatic brain injury (TBI)
Regulatory Designation

U.S. - Orphan Drug (Treat moderate and severe traumatic brain injury (TBI));
EU - Orphan Drug (Treat moderate and severe traumatic brain injury (TBI))

Partner

Sihuan Pharmaceutical Holdings Group Ltd.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$7.5M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today